Cai Zhaohui, Liang T Jake, Luo Guangxiang
Department of Microbiology, Immunology, and Molecular Genetics, University of Kentucky College of Medicine, Lexington, Kentucky 40536, USA.
J Virol. 2004 Apr;78(7):3633-43. doi: 10.1128/jvi.78.7.3633-3643.2004.
Replication of nearly all RNA viruses depends on a virus-encoded RNA-dependent RNA polymerase (RdRp). Our earlier work found that purified recombinant hepatitis C virus (HCV) RdRp (NS5B) was able to initiate RNA synthesis de novo by using purine (A and G) but not pyrimidine (C and U) nucleotides (G. Luo et al., J. Virol. 74:851-863, 2000). For most human RNA viruses, the initiation nucleotides of both positive- and negative-strand RNAs were found to be either an adenylate (A) or guanylate (G). To determine the nucleotide used for initiation and control of HCV RNA replication, a genetic mutagenesis analysis of the nucleotides at the very 5' and 3' ends of HCV RNAs was performed by using a cell-based HCV replicon replication system. Either a G or an A at the 5' end of HCV genomic RNA was able to efficiently induce cell colony formation, whereas a nucleotide C at the 5' end dramatically reduced the efficiency of cell colony formation. Likewise, the 3'-end nucleotide U-to-C mutation did not significantly affect the efficiency of cell colony formation. In contrast, a U-to-G mutation at the 3' end caused a remarkable decrease in cell colony formation, and a U-to-A mutation resulted in a complete abolition of cell colony formation. Sequence analysis of the HCV replicon RNAs recovered from G418-resistant Huh7 cells revealed several interesting findings. First, the 5'-end nucleotide G of the replicon RNA was changed to an A upon multiple rounds of replication. Second, the nucleotide A at the 5' end was stably maintained among all replicon RNAs isolated from Huh7 cells transfected with an RNA with a 5'-end A. Third, initiation of HCV RNA replication with a CTP resulted in a >10-fold reduction in the levels of HCV RNAs, suggesting that initiation of RNA replication with CTP was very inefficient. Fourth, the 3'-end nucleotide U-to-C and -G mutations were all reverted back to a wild-type nucleotide U. In addition, extra U and UU residues were identified at the 3' ends of revertants recovered from Huh7 cells transfected with an RNA with a nucleotide G at the 3' end. We also determined the 5'-end nucleotide of positive-strand RNA of some clinical HCV isolates. Either G or A was identified at the 5' end of HCV RNA genome depending on the specific HCV isolate. Collectively, these findings demonstrate that replication of positive-strand HCV RNA was preferentially initiated with purine nucleotides (ATP and GTP), whereas the negative-strand HCV RNA replication is invariably initiated with an ATP.
几乎所有RNA病毒的复制都依赖于病毒编码的RNA依赖性RNA聚合酶(RdRp)。我们早期的研究发现,纯化的重组丙型肝炎病毒(HCV)RdRp(NS5B)能够利用嘌呤(A和G)而非嘧啶(C和U)核苷酸从头起始RNA合成(G. Luo等人,《病毒学杂志》74:851 - 863,2000年)。对于大多数人类RNA病毒,正链和负链RNA的起始核苷酸均被发现为腺苷酸(A)或鸟苷酸(G)。为了确定用于HCV RNA复制起始和控制的核苷酸,我们利用基于细胞的HCV复制子复制系统对HCV RNA 5'和3'末端的核苷酸进行了遗传诱变分析。HCV基因组RNA 5'末端的G或A能够有效地诱导细胞集落形成,而5'末端的核苷酸C则显著降低了细胞集落形成的效率。同样,3'末端核苷酸U到C的突变对细胞集落形成效率没有显著影响。相比之下,3'末端U到G的突变导致细胞集落形成显著减少,而U到A的突变则导致细胞集落形成完全消失。对从G418抗性Huh7细胞中回收的HCV复制子RNA进行序列分析揭示了几个有趣的发现。首先,复制子RNA的5'末端核苷酸G在多轮复制后变为A。其次,在从用5'末端为A的RNA转染的Huh7细胞中分离的所有复制子RNA中,5'末端的核苷酸A都稳定存在。第三,用CTP起始HCV RNA复制导致HCV RNA水平降低10倍以上,这表明用CTP起始RNA复制效率非常低。第四,3'末端核苷酸U到C和 - G的突变都回复为野生型核苷酸U。此外,在从用3'末端为核苷酸G的RNA转染的Huh7细胞中回收的回复子的3'末端鉴定出额外的U和UU残基。我们还确定了一些临床HCV分离株正链RNA的5'末端核苷酸。根据特定的HCV分离株,在HCV RNA基因组的5'末端鉴定出G或A。总的来说,这些发现表明正链HCV RNA的复制优先用嘌呤核苷酸(ATP和GTP)起始,而负链HCV RNA复制总是用ATP起始。